Back

The Adipo-B Index as a Novel Integrator of Glycemic and Lipid Homeostasis: a Multiple-Therapy Validation Study

2026-02-16 endocrinology Title + abstract only
View on medRxiv
Show abstract

ObjectiveTo introduce and evaluate the clinical utility of the "adipo-B index" as a novel metric of the adipose tissue-pancreatic beta cell axis. To our knowledge, no prior clinical metric has integrated adipose tissue insulin resistance and pancreatic beta-cell function into a single index applicable across therapeutic classes. MethodsTreatment-naive subjects with T2DM received monotherapy with modified traditional diet for diabetes (MJDD, n=61), canagliflozin (n=67), pioglitazone (n=54), or s...

Predicted journal destinations